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ABSTRACT  The muscarinic acetylcholine receptor (mAChR)-stimulated, inwardly 
rectifying K + current (Ir4^Cal) was examined in single bullfrog atrial cells using the 
whole-cell patch clamp technique. Iir  was activated either by bath addition of 1 
/~M ACh or via activation of the G protein, Gk, with guanosine-'r-thiotriphosphate 
(GTP3~S). Arachidonic  acid  (AA)  modulated  IKtAC~] under  both  conditions.  AA 
decreased mAChR-stimulated Ir4Aoq and increased the rate of decay from the peak 
current  (desensitization).  In  addition,  AA  affected  GTPTS-activated  IK[AC~] by 
modulation of C~. The effects of AA and its metabolites on Gk were assessed by 
examining their effects on both the basal rate of Gk activation by GTPTS, and the 
mAChR-mediated  increase  in  activation  rate produced  by nanomolar ACh.  AA 
increased  the  basal  rate  of GTP"/S-mediated IKtxchl activation,  but  reduced  the 
ACh-induced  augmentation  of this  rate.  All  of the  effects  of AA  on  GTP3,S- 
mediated IgtACa] activation were produced by metabolites. A lipoxygenase inhibitor, 
nordihydroguaiaretic acid (NDGA), decreased the basal and ACh-enhanced rate of 
IKIAChl activation in both the presence and absence of exogenous AA. In contrast, 
indomethacin (INDO), a cyclooxygenase inhibitor, increased the basal rate of IKtAChj 
activation by GTP'rS in both  the  presence  and  absence  of exogenous AA,  and 
reversed  the  effects  of AA  on  the  ACh-augmented  basal  rate.  AA  metabolites 
produced via lipoxygenase and cyclooxygenase pathways thus have opposing effects 
on the signal transduction  pathway from mAChR to IV4ACh]. We directly tested a 
lipoxygenase pathway metabolite, LTC4, on GTP3,S-mediated IK[AChl activation and 
found that it not only overcame the inhibitory effects of NDGA, but also increased 
both the basal and ACh-augmented rate of Ir4Aoq activation. From these data, we 
propose that AA metabolites modulate the function  of G k by altering its kinetic 
properties. 
Address reprint requests  to Dr. Gerda E. Breitwieser, Department of Physiology, Johns Hopkins 
University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205. 
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INTRODUCTION 
Acetylcholine (ACh)  binding  to  muscarinic  acetylcholine receptors  (mAChR)  on 
atrial cells activates an inwardly rectifying potassium current, IKE^Chl (Gamier et al., 
1978; Simmons and Hartzell, 1987). Although it is clear that a GTP-binding protein 
(Gk)  mediates the coupling between mAChR and the ion channel (Breitwieser and 
Szabo,  1985;  Pfaffinger et  al.,  1985),  the  exact nature  of the  coupling remains 
elusive. 
Activation of IKtAChl by G~ has been suggested to involve the direct interaction of 
G k with both mAChR and the ion channel. Initial experiments (Logothetis et al., 
1987;  Yatani et al.,  1987)  demonstrated that isolated, preactivated G  proteins (or 
activated subunits) were capable of inducing IKEAChl in excised patches of atrial cell 
membranes. Cytoplasmic second messengers were apparently not involved, since the 
channels were not activated in on-cell patches when ACh was applied to the cell, but 
were activated when ACh was included in the patch pipette during on-cell recording 
(Soejima and Noma, 1984). 
The ability to apply isolated G protein subunits to the cytoplasmic face of excised 
membrane patches has produced some interesting insights into G protein-mediated 
signal transduction. Both isolated a  (for review, see Brown and Bimbaumer, 1988) 
and /3~, (for review,  see  Neer  and Clapham,  1988)  subunits have been  shown to 
produce  IKEAChl-like currents.  The  mode  of action  of the  isolated  subunits  was 
thought to be  the  same:  insertion of either the a  or /3~, subunits into  the  patch 
membrane, and direct interaction with the IKEACal  channel protein. 
Although the initial reports of/37-mediated activation of IKEAChl assumed a direct 
interaction of the subunits with the IKtAChl channel (Logothetis et al., 1987), it now 
seems  clear  that the /3")' subunits are  mediating at least some of their effects via 
activation of phospholipase A 2 (PLA2). G  proteins are involved in the activation of 
PLA2 (for review, see Burch, 1989), and it has been suggested that in some systems, 
activation is mediated by/37 subunits (Jelsema and Axelrod,  1987).  Antibodies to 
PLA  2 block the ability of/37 subunits to activate IKtAChl  in excised patches (Kim et al., 
1989),  and bath application of arachidonic acid (AA), blockers of AA metabolism, 
and  5-1ipoxygenase  metabolites  are  all  capable  of altering IKEAChl single  channel 
activity (Kim et al.,  1989;  Kurachi et al.,  1989).  Pertussis toxin did not block the 
ability  of AA  metabolites  to  modulate  IKtAChl (Kurachi  et  al.,  1989),  nor  were 
inhibitors of AA metabolism able to block the GTP'yS-medlated activation of IKIAChl' 
suggesting  that  a  subunits  mediate  IKEACal activation  in  the  absence  of  the  /37 
pathway. Taken together,  the  results of experiments with exogenously applied G 
protein subunits suggested that IKEAC~I may be modulated by complex interactions 
between the a  subunit and products of/3"y-activated metabolic pathways. 
To dissect out the effects of AA and its metabolites on each of the components of 
the normal activation cascade, we used a kinetic approach which can direcdy assess 
the functional state of G k (Breitwieser and Szabo,  1988).  The key feature of the 
method is the use of high concentrations of hydrolysis-resistant GTP analogues at 
fixed ratios with GTP (e.g., for GTP'yS/GTP >  20/1), which results in the irrevers- 
ible  activation of every Gk molecule that releases its bound GDP.  This process  is 
directly reflected in the appearance of IK[ACh]- Under these special conditions, the SCHERER AND BR~rWI~EP.  Arachidonic  Acid Alters Muscarinic K + Channel Activation  737 
rate  of IKt^Ch] activation  is  likely  to  correspond  to  the  rate-limiting  step  in  the 
receptor-independent  activation of G k, namely, GDP release  (Breitwieser and Szabo, 
1988;  Szaho  and  Otero,  1989).  The  kinetic  approach  proved  to be  a  remarkably 
reproducible and sensitive assay of the state of G k, and amplified the effects of AA 
and  its  metabolites.  Our  results  suggest  that  AA can  modulate  both  the  rate  of 
mAChR-independent  Gk activation and the ability of ACh to increase this  rate.  AA 
metabolites  thus  set  the  "tone"  of the  mAChR--ak-IKtAC~] pathway.  A  preliminary 
account of these results has appeared  (Scherer and Breitwieser,  1990). 
METHODS 
Solutions 
HEPES-buffered  Ringer solution contained  (in  millimolar):  NaCI,  90;  KCI,  2.5;  MgC12, 5; 
CaCI2, 2.5; and HEPES, 20; pH 7.4. For the electrophysiological experiments, 5 #M TTX and 
0.5 mM CdCI~ were added to block Na  § and Ca  2+ currents, respectively. Other additions to 
the superfusing solution are noted in the figures. Stock solutions of AA (20 mM, in ethanol) 
were  stored  in  aliquots  under  nitrogen  at  -20~  Fresh  aliquots  were  used  daily.  The 
sulfidopeptide leukotriene C 4 (LTC4) was purchased in ethanol and stored at -80~  until the 
day of the experiment. Aiiquots were diluted into HEPES-buffered Ringer and used within 4 
h. Stock solutions of indomethacin (INDO) in ethanol and nordihydroguaiaretic acid (NDGA) 
in dimethylsulfoxide were made fresh daily.  Neither solvent (maximal concentration,  3.0%) 
had  any  effect  on  GTP3'S- or ACh-stimulated  IKCAChl (data  not  shown).  The  intracellular 
solution contained (in millimolar): K § aspartate, 80; KCI, 30; HEPES, 5; K + EGTA, 1; GTP, 
0.05; MgATP, 5; pH 7.4. When present, GTP'yS was added to the intracellular solution as the 
Li salt. 
All  salts  were  reagent  grade.  All  chemicals  and  nucleotides  were  obtained  from Sigma 
Chemical Co. (St. Louis, MO) except HEPES (Ultrol) and AA (Calbiochem Corp., San Diego, 
CA), and LTC  4 (Cayman, Ann Arbor, MI). 
Cell Dissociation 
Isolated  atrial  cells  from  the  bullfrog  Rana  catesbeiana  were  obtained  as  described  by 
Fischmeister and Hartzell (1986) with minor modifications. Briefly,  the heart was removed, 
rinsed in HEPES-buffered Ringer, and then perfused with 25 ml Ca~+-free Ringer solution (in 
millimolar):  NaCI,  88.4;  KCI,  2.5;  MgCI~, 1.8;  NaHCOs,  23.8;  NaH2PO  4,  0.6;  and  Na  § 
pyruvate,  2.5;  fatty  acid-free  bovine  serum  albumin,  1  mg/ml;  and  MEM  vitamins  and 
essential amino acids, 1 #l/ml, equilibrated with 5% CO  s at 28~  The heart was then perfused 
(at 28~  with 25 ml of a recirculating dissociation solution (Ca2+-free  Ringer solution with 5 
mM  creatine,  50  U/ml  penicillin,  and  50  #g/ml  streptomycin)  containing  10  mg trypsin 
(bovine  pancreas;  Boehringer  Mannheim  Biochemicals,  Indianapolis,  IN)  and  62.5  mg 
collagenase B (Clostridium histolyticum,  lot 144702; Boehringer Mannheim Biochemicals). After 
60-90  min the heart was placed  in dissociation  medium without enzymes and  the atrium 
dissected.  Cells were released by gentle agitation of the atrium in dissociation medium for 
30-45 min. The myocytes were then diluted twofold with storage solution (Ca2+-free  Ringer 
solution with 0.9 mM CaCI~; 5 mM glucose; 1 #l/ml MEM vitamins and essential amino acids; 
50  U/ml  penicillin;  and  50  /~g/ml  streptomycin).  Cells  remained  viable  for  6-8  h  after 
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Electrophysiology 
Currents were measured by the whole-cell  patch clamp technique  (Hamill et al.,  1981)  as 
previously described (Breitwieser  and Szabo, 1985,  1988).  Patch electrodes were fabricated 
from square bore glass (Glass Co. of America, MiUviUe, N  J) on a Flaming Brown micropipette 
puller (Sutter Instrument Co., San Rafael, CA) and were used without firepolishing.  Junction 
potentials  were  not  corrected.  Voltage  pulses  were  generated  with  a  computer-loaded 
Arbitrary  Waveform generator  (model  75;  Wavetek,  San  Diego,  CA).  The  protocol  for 
monitoring IKtAChl used sequential 250-ms steps to --90, -- 125, and -5 mV from the holding 
potential  of  -85  mV  (with  return  to  the  holding  potential  between  steps).  Steady-state 
current-voltage relationships were determined by assessing the average current at the end of 
250-ms voltage steps. Pulse protocols were applied to the cell continuously from the moment 
of patch rupture. A 5-mV hyperpolarizing step from the holding potential was included in all 
pulse protocols to allow continuous monitoring of the pipette series resistance, which was not 
electronically  compensated. Currents were measured with a  patch clamp amplifier (EPC-7; 
List,  Darmstadt-Eberstadt,  FRG) and monitored with an oscilloscope (model 310;  Nicolet 
Instrument  Corp.,  Madison,  WI).  Signals  were  converted  to  digital  signal  via  a  PCM-1 
instrumentation adaptor (Medical  Systems  Corp., Greenvale, NY) and stored on VCR tape 
(VHS,  model AG-1230;  Panasonic,  Secaucus,  NJ).  Rates were estimated by recording the 
analogue signal on either an Astromed (model Z100; Astromed, West Warwick, RI) or Gould 
recorder (model 220; Gould Inc., Cleveland, OH). All experiments were performed at room 
temperature (22-24~ 
RESULTS 
AA Alters Both the Magnitude  and Time Course of lr4aC~l Activation 
ACh induces an inwardly rectifying K + current in isolated bullfrog atrial myocytes, as 
illustrated  by the  steady-state current-voltage  relationship  shown  in  Fig.  1 A.  To 
assess  whether  AA  could  activate whole-cell  IKt^czl to  a  level comparable  to  that 
obtained with ACh, we superfused bullfrog atrial cells with 20 #M AA. AA produced 
minimal activation of Ix~E^ca] (Fig. 1 B): in this particular experiment, there was a 3-pA 
increase in outward current at  -5  inV. 
Also illustrated in Fig. 1 B is the response of the myocyte to ACh in the continued 
presence of AA. After a  2-rain exposure to 20 #M AA, stimulation with  1 #M ACh 
elicited a  smaller current  than that seen in response to ACh in the absence of AA 
(compare Fig.  1, A  and B).  Since AA also altered the kinetics of IKEAC~J decay after 
ACh application  (see below), the mean ACh-induced I~E^c~l in the presence of AA 
was assessed 30 s after the peak response and was 37.8  •  4.0 pA (SEM; n  =  17) at 
-  5 mV. This is less than half of the steady-state IKEAChl observed in the absence of AA 
(88.1  _+ 8.1  pA; n  =  32). 
AA modified the kinetics of decay of the current induced by ACh.  Illustrated in 
Fig. 2 A is the control time course of decay of IV4AC~1 at -- 5 mV in response to 1 #M 
ACh. Application of ACh induced a peak IXqAC~j which decreased to 57 +  5% (n =  4) 
of peak within  1 rain.  There was, in addition  to the decrease in magnitude of the 
peak current in the presence of 20 #M AA, a more marked time-dependent decline 
in I~EAc~I (Fig. 2 B). In this representative experiment, the peak IKEACh  I in the presence 
of AA was lower than control, and IKEACal decayed to <20% of peak current within 1 SCHERER AND BREITWIESER  Arachidonic Acid Alters Muscarinic K + Channel Aaivation  739 
min. I~[A(m]  after l  min of I  #M ACh in the presence of 20 #M AA was only 30 + 6% 
of the corresponding peak IKtACN alSO measured in the presence of AA (n =  4). 
The inhibitory effects of AA on Ixt^Chl induced by ACh may be due to either (a) a 
direct block of the open IxtACN channel by AA or a metabolite, or (b) an effect of AA 
on  mAChR and/or Gk.  The  next  section uses  GTP~,S,  a  hydrolysis-resistant  GTP 
analogue, to examine whether AA can block the Ixt^ch]  channel directly. 
AA Does Not Block Open l~ac~  1 
Including 1 mM GTP~,S in the electrode solution induces a  slow, mAChR-indepen- 
dent activation of IV~ACN, which reaches a  maximum, steady-state IK[ACh] in ~3 min 
(Breitwieser  and Szabo,  1988).  Addition of 1 #M ACh does not induce additional 
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FIGURE  1.  Effect  of arachidonic acid on the steady-state  current-voltage relationship  of 
atrial cells. Steady-state currents were measured at the end of 250-ms voltage pulses from a 
holding potential of -  85 mV. Traces were not corrected for series resistance across the patch 
pipette:  at the highest  applied  potentials,  the voltage offset amounted to <3 mV. The patch 
pipette  contained control intracellular  solution,  and the superfusing Ringer solution  con- 
tained 5 #M Trx and 0.5 mM CdCI~ to block Na  + and Ca  2+ currents, respectively. ,4, Control: 
background K  + current (open circles) and current after 30 s superfusion with a Ringer solution 
containing 1 #M ACh (solid circles). B, Arachidonic acid: background K § current (open circles), 
current after 90 s exposure to 20 #M AA (open tr/ang/es) and current after 30 s superfusion of 
1 #M ACh in the continued presence of 20 #M AA (solid circles). 
current once the steady-state IK[A~] has been reached.  Furthermore, unlike IIqACh] 
induced by ACh in the presence of GTP, the current generated in the presence of 
GTP~,S  does not decay after removal of ACh. A representative time course showing 
the slow, GTP~/S-mediated generation of IVCACN and parameters used to calculate the 
basal  activation  rate  are  illustrated  in  Fig.  3.  The  basal  rate  of GTPqcS-mediated 
IlqACa] activation is calculated by dividing the absolute rate (picoamperes per minute) 
of current increase during the linear, initial rate portion of IX[ACa] activation by the 
final steady-state current, IKt^c~}, (picoamperes). 
Also  illustrated  in  Fig.  B  is  the  lack  of effect  of  20  #M  AA  on  IK[AC  N  once 
GTP~,S-dependent activation of G k,  and hence IK[^czl,  has occurred. This suggests 
that  the  inhibition  by AA of IK{AChl,~ activated  by ACh  in  the  presence  of GTP 740 
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FIGURE 2.  Effect of AA on the time course of IttAChl decay in response to ACh. IK[ACh] WaS 
monitored by meaSuring the current at the end of 250-ms voltage pulses to -5  mV, from a 
holding potential of -85 mV. Plots are aligned to allow comparison of the time course after 
ACh application.  Data are plotted from the time of patch rupture.  The pipette  contained 
control intracellular solution. A, Time course of Iv4ACM  decay after exposure to 1 #M ACh. B, 
Time course of/K[ACh]  decay after exposure to 1 #M ACh in the presence of 20 #M AA. The 
cell waS superfused sequentially with Ringer solution containing first 10 and then 20 #M AA. 
/K[ACh] was  then elicited by switching to a Ringer solution containing both 20 #M AA and 1 #M 
ACh. 
(Fig. 2 B) is not due to a direct block of the open Iv,4AcM channel by AA, and further 
implies  that AA must  produce  its  effect by modulating mAChR,  Gk,  and/or  their 
interactions. 
AA and Its Metabolites Modify the Rate of GTP"~S-mediated IrgaChl Activation 
The physiological effects of AA can be complex since AA is rapidly metabolized via 
two  major  routes:  the  cyclooxygenase and  lipoxygenase  pathways.  Blocking either 
pathway results in both reduced production of metabolites via the blocked pathway SCHERER AND BREITWIESER  Arachidonic Acid Alters Muscarinic K + Channel Activation  741 
and enhanced production of metabolites via the unblocked pathway. We therefore 
examined the effects on IK[ACa] activation rates of blocking either the cyclooxygenase 
(with INDO) or lipoxygenase (with NDGA) pathways. We summarize our conclusions 
in  Fig.  4  to aid in an  examination of the data.  As illustrated,  cyclooxygenase and 
lipoxygenase pathway metabolites  have opposing effects on IKtACh] activation.  The 
rate of IKtACh] activation is the result of a balance between the inhibitory actions of 
cyclooxygenase metabolites and the stimulatory effects of lipoxygenase metabolites, 
including LTC  4. Thus, blocking production of lipoxygenase metabolites with NDGA 
inhibits  IK[ACh] activation, while blocking production of cyclooxygenase metabolites 
with INDO potentiates IK[AC~] activation. In this section, the rate of IK[ACh] activation 
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FIGURE 3.  Effect of AA on  IK[A~ ] activated by GTP'?S.  1 mM GTP'),S (20/1 ratio with GTP) 
was added to the control intracellular solution. Generation of I~tAchl by GTP')'S was monitored 
from the  moment of patch  rupture  by periodic  250-ms  voltage steps  from the  holding 
potential (- 85 mV) to -  5 mV. Maximal IKEAChl  was assessed by switching to a Ringer solution 
containing 1 #M ACh, which resulted in a peak current that decayed to a steady-state level 
(IKtAC~],)-  The rate of activation of IKtAC~]  Was calculated from the slope of the change in current 
with time (picoamperes per minute) normalized to I~Ac~lu (picoamperes). For this cell,  the 
basal activation rate was 0.22 min  -l. After IKtAChl,,  was reached, ACh was washed from the bath 
to test for complete irreversibility  of I~AC~  1  and then the superfusing solution was switched to 
a Ringer solution containing 20 #M AA, as indicated in the figure. 
in the presence of GTP'?S is used to isolate the Gk--IIqAC  M interaction and to examine 
the effect of AA and its metabolites on the rate of GDP release by G k. 
The rate of IKtA~I activation induced by hydrolysis-resistant guanine nucleotides 
(GXP) depends only on the ratio of GXP/GTP for GXP concentrations >0.1 mM. At 
high  ratios  (>-20/1  for GTP~,S)  the  maximal basal IKt^cal activation rate  has been 
shown  to  be  equivalent  to  the  rate  of release  of GDP  from G k (Breitwieser  and 
Szabo,  1988; Szabo and Otero,  1989), and is of the order of 0.3 rain -1. The results 
of the previous section demonstrate that AA does not alter IKEACa] once G k has been 
fully activated by GTP~'S, implying that the channel itself is not blocked by AA. Thus, 
it  is  possible  to  use  the  rate  of  IKtAC~] activation  to  assess  whether  AA  or  its 742  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  ￿9 VOLUME  96  ￿9  1990 
metabolites  can  affect  the  activation  of  Gk  by  GTP3,S,  or  the  interaction  of 
Gk-GTP'yS with the channel. The tabulated data are illustrated in Fig. 5. With a ratio 
of 20/1  of GTP3,S/GTP (1  mM GTP3,S/50 #M GTP), the IKtAC~I  activation rate was 
0.28  -+  0.02  min -1  (SEM; n  =  18),  as has been shown previously (Breitwieser and 
Szabo,  1988).  In the presence of 20 #M AA this rate was significantly increased to 
0.47  _+ 0.03 min -1 (n ---- 24). Similar results were obtained in the presence of 10 #M 
atropine (control, 0.27 -+ 0.03, n  =  3; 20 #M AA, 0.44 _+ 0.05, n  =  5), implying that 
AA does not produce its effect by binding to the agonist site of mAChR. While an 
effect of AA on unoccupied mAChR cannot be ruled out, it is more likely that the 
ability of AA to increase the basal rate of IK[AChl activation by GTP3,S may be ascribed 
to either an effect of AA (or its metabolites) on the release of GDP from Gk or to an 
enhancement of the ability of activated G k to interact with the channel. 
Also illustrated in Fig. 5 are the effects of INDO and NDGA on the basal rate of 
/K[ACh] activation under control conditions, and in the presence of either 20 #M AA 
or  10 #M LTC  4.  INDO (10 #M) increased the rate of IK[A~] activation in both the 
absence and presence of exogenously applied AA. In contrast to the effect of INDO, 
NDGA (10 ~M) reduced the rate of IKtAC~I activation by ~30%. NDGA also blocked 
the increase in the basal rate determined in the presence of 20 #M AA. It should be 
~"~176  ~  stimulatory metabolites, e.g. LTC  4 
(/,y~~  inhibitory metabolites 
FmU~,E 4.  Major pathways for AA metabolism. See text for details. 
pointed out that NDGA reduced the magnitude of IKtAC~] elicited by either ACh or 
GTP3,S  (data  not  shown).  However,  since  the  rate  of  GTP~,S-mediated  IKtAC~] 
activation was always normalized to the final ACh-stimulated IKtAC~I,~  in the same cell 
(as  illustrated  by  the  control  activation  rate  in  Fig.  3),  the  rates  are  directly 
comparable with those measured in the absence of NDGA. 
These data  suggest  that  normal cellular AA metabolism must contribute  to  the 
ability of G k to release  GDP and become activated.  This is suggested by both  the 
effects  of  NDGA  and  INDO  on  basal /K[AChl activation  rates  in  the  absence  of 
exogenous AA, and by the fact that the effects of the inhibitors are the same in the 
presence of exogenous AA. Furthermore, the data imply that metabolites produced 
by both  the cyclooxygenase and lipoxygenase pathways modulate  Gk: lipoxygenase 
metabolites  appear  to  enhance  the  rate  of  Gk  activation,  while  cyclooxygenase 
metabolites appear to inhibit it. 
To confirm this hypothesis, we examined the effects of a  5-1ipoxygenase metabo- 
lite, LTC4, on the rate of Ia[A~l activation by GTP'?S, in the presence and absence of 
either NDGA or INDO. LTC  4 was chosen for two reasons: (a) it had been shown to 
produce IKtAChl single channel activity (Kim et al., 1989; Kurachi et al., 1989) and (b) 
it is the sulfidopeptide leukotriene that gives rise to a variety of further metabolites, SCHERER AND BREITWIESER Araehidonic Acid Alters Muscarinic K + Channel Activation  743 
allowing isolation of one branch  of the  5-1ipoxygenase metabolite  cascade.  10 #M 
LTC  4 in  the  absence  of ACh  had  only a  minor effect  on whole-cell IK[ACh] in  the 
presence  of GTP  (<2  pA at  -5  mV),  but  it  gready accelerated  the  basal  rate  of 
GTP3,S-mediated IK[ACh] activation,  as illustrated  in Fig.  5.  Significandy, NDGA did 
not block the stimulatory effect of LTC  4. INDO on the other hand acted synergisti- 
cally with LTC4, producing a  rate of IgtA~] activation  10-fold higher than that seen 
under control conditions. These results are consistent with products of AA metabo- 
lism  mediating  opposing effects  on  the  rate  of GTP3~S-mediated  IK[A~]  activation, 
and hence on the rate of GDP release from G k. 
1.0. 
0.8  ~  NDGA 
EEE] INDO 
T  0.6. 
E 
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FIGURE 5.  Effect of AA, me- 
tabolites,  and  blockers  on the 
basal  rate  of IKtAO~} activation. 
The basal rate of IKtAChl activa- 
tion  was  measured  as  illus- 
trated in Fig.  3, using an intra- 
cellular  solution  containing  1 
mM GTP~,S. Immediately upon 
patch rupture  the superfusing 
solution  was  changed  to  a 
Ringer solution containing the 
illustrated mixes of control, 20 
/zM AA, or 10 #M LTC  4, plus 
the indicated inhibitors  (either 
10 #M NDGA or 10/~M INDO). Bars indicate the mean •  SEM of four or more observations. 
The bar indicating the mean rate of activation in the presence of LTC  4 +  INDO (3.6 •  0.18 
min-') was truncated for clarity. The rate of IKtACh] activation in the presence of either 20 #M 
AA or  10  #M  LTC  4 was significantly greater  than  the  control basal  rate  (P< 0.01).  The 
blockers,  NDGA or INDO, significantly altered  the corresponding rate  in  the  absence  of 
blocker (P < 0.01), except for the effect of NDGA in the presence of LTC  4 (which was not 
significantly different from the rate in the presence of LTC  4 alone). The rate in the presence 
of AA +  NDGA was not significantly different from the rate in the presence of NDGA alone. 
AA and Its Metabolites Modulate the mAChR-induced Increase in the Rate of 
GTP~S-mediated Ir4aC~l Activation 
Nanomolar concentrations of ACh, which do not activate appreciable IK[ACh] in the 
absence  of GTP3,S,  lead  to a  marked  acceleration  of the  rate  of GTP3,S-mediated 
Ir4ACh] activation  (Breitwieser  and  Szabo,  1988).  This  is  consistent  with  the  notion 
that mAChR activation enhances the rate of GDP release  from Gk,  and reflects the 
mAChR-G k interaction.  Fig.  6  illustrates  the  action of 5  nM  ACh  on  the  rate  of 
activation of IV4ACh] at high GTP3,S/GTP (20/1). The current was sampled at -5  mV 
from a  holding potential  of -85  mV starting immediately after  breaking into  the 
cell.  GTP3,S (1  mM) in the pipette  quickly began to diffuse into the cell and IKt^Chl 
began  to activate  at  the  mAChR-independent  rate.  The  superfusing  solution  was 
then switched to one containing 5 nM ACh, causing an abrupt increase in the rate of 
IK[ACh] activation.  IK[AC~],, Was  then  assessed  by  switching  to  a  Ringer  solution 744  THE JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  96  ￿9  1990 
containing  1  #M  ACh.  In  this  cell,  5  nM  ACh  had  already induced  the  maximal 
IKtA~] and  1  #M  ACh  thus  had  no  further  effect.  Both  the  basal  and  the  ACh- 
augmented rates were normalized to this maximal IK[AChl," In this particular cell the 
rates were 0.23 and 5.07 min -1, respectively. We examined the effects of AA and its 
metabolites  on  the  ACh-induced  increase  in  the  rate  of activation  of IK[AC~]. AA, 
metabolites, and/or blockers were present from the moment of patch rupture, and 
various ACh concentrations were applied as described above. 
We first examined the effects of LTC  4 on ACh-augmented IK[AChl activation, since 
its effects on the basal rate of IK[ACZ] activation were purely stimulatory. Confirming a 
previous study (Breitwieser and Szabo, 1988), ACh over the range from 1 to 10 nM 
produced an enhancement of the rate of GTP~,S-mediated IK[ACh] activation. LTC4, 
which  stimulated  the basal  rate  of IK[^Ch] activation by GTP~/S, also enhanced  the 
250 
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0  1  2  3 
time  (rain) 
FIGURE 6.  Effect of ACh on the activation of IK[ACh] by GTP3'S. The intraceUular  solution 
contained 1 mM GTP~fS. After a basal rate of IKtACh] activation was observed, the superfusing 
solution was switched to one containing 5 nM ACh, as indicated by the bar. The rate of IKiACh] 
activation increased abruptly. IKtACh]~ was determined by addition of 1 #M ACh, which did not 
significandy increase the current. The basal rate of activation for this cell was 0.23 min  -1 and 
the rate in the presence of 5 nM ACh was 5.07 min  -l. 
ACh-mediated increase in this rate (Fig.  7). This effect of LTC  4 was not altered by 
the  presence  of 10  #M  NDGA,  although  NDGA by itself virtually prevented  the 
activation of IK[ACZ], even in  the  presence of 10  nM  ACh.  The ability of LTC4 to 
overcome the block by NDGA suggests that NDGA is specifically inhibiting metabo- 
lism via lipoxygenases (and preventing production of a  required activating metabo- 
lite), rather than interacting nonspecifically with either m_AChR or the channel. 
The effects of exogenously applied AA are more complex than  those of LTC4, 
since both stimulatory and inhibitory metabolites are produced, as suggested by the 
results in Fig.  5. To simplify an examination of the data, the effects of NDGA and 
INDO on the ACh-augmented rate of la[^Ch] activation in the presence of exogenous 
AA are displayed separately. SCHERER AND BREITWIESER Arachidonic Acid Alters Muscarinic K + Channel Aaivation  745 
20  #M  AA  (Fig.  8 A)  produced  a  rightward  shift  in  the  activation  curve  as 
compared  with  the  control  (in  contrast  to  its  stimulatory  effect  on  mAChR- 
independent  IKt^Ch] activation  rates  in  Fig.  5).  10  #M  NDGA,  as  discussed  above, 
virtually blocked the enhancement  of Ir4ACh] activation rate produced by ACh, and 
AA  was  not  able  to  overcome  this  block.  These  results  suggest  that  inhibitory 
metabolites  (cyclooxygenase pathway)  have  a  greater  effect  on  the  ACh-mediated 
rate of IKt^tm] activation than on the mAChR-independent basal rates. 
10 #M INDO (Fig. 8 B), by blocking utilization of exogenously applied AA via the 
cyclooxygenase  pathway,  produced  an  ACh-augmented  rate  of IK[AO~I activation 
which was not significantly different from control. Neither INDO  +  AA nor INDO 
alone  was  able  to  shift  the  ACh-mediated  activation  curve  to  the  level  of LTC  4, 
8- 
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FIGURE 7.  LTC  4 modulation  of the  ACh-induced increase  in  IKtACh] activation  rate.  The 
ACh-augmented rate of IK[ACh] activation was measured as described in Fig.  6. LTC  4 and/or 
NDGA were present from the time of patch rupture. After a basal rate of IK[ACh]  activation was 
observed, the superfusing solution was switched to one containing the indicated concentration 
of ACh in the continued presence of LTC  4 and/or NDGA, as indicated. The control curve was 
determined as in Fig.  6 without the addition of LTC  4 or NDGA. Each value represents the 
mean _+ SEM of four or more determinations. Squares,  control; circles, 10 #M LTC4; triangles, 
10 #M NDGA; inverted triangles,  10 #M LTC  4 +  10 #M NDGA. 
suggesting that the normal ACh-mediated augmentation of the IK[ACh]  activation rate 
(in the absence of any exogenous lipid metabolites or blockers) is limited by cellular 
production of stimulatory metabolites,  such as LTC  4. The ACh-induced augmenta- 
tion  of  the  IK[ACh] activation  rate  in  the  absence  of exogenous  AA  metabolites 
represents  the  maximal  rate  at  which  LTC  4  or  its  further  metabolites  can  be 
produced.  Only when exogenous LTC4 is added to the superfusing solution do the 
activation curves shift to the left of control, implying that cellular metabolism, under 
these conditions, is rate limiting. The results further suggest that significant levels of 
the inhibitory metabolite(s)  are not produced unless exogenous AA is provided. An 
excess of AA saturates  the lipoxygenase pathways and results  in the production of 746  THE JOURNAL OF GENERAL  PHYSIOLOGY  ￿9  VOLUME 96 ￿9 1990 
metabolites via the cyclooxygenase pathway, which apparently has a lower affinity for 
AA than the lipoxygenase pathway. 
DISCUSSION 
In this paper we present evidence that AA metabolites modulate the ACh-stimulated 
K + channel of bullfrog atrial cells by altering the function of the signal-transducing, 
GTP-binding protein,  G k, which couples mAChR to the ion channel. AA (20 #M) is 
able to elicit a modest activation of IKtACh]  under whole-cell recording conditions (2-4 
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FIGURE 8.  AA modulation of 
the  ACh-induced  increase  in 
IKtACZ] activation  rate.  The  ef- 
fect of AA, INDO, and NDGA 
on  the  ACh-induced  increase 
in  IKtACh] activation  rate  was 
measured  as described in  Fig. 
7.  Each  value  represents  the 
mean  _+ SEM of four or more 
observations. The control rate 
of  ACh-induced  increase  in 
IKtACh] activation rate (squares) is 
replotted from Fig.  7 for com- 
parison.  A,  Effect  of  AA 
and/or NDGA on the dose re- 
sponse curve to ACh. Squares, 
control; circles, 20 #M AA; tr/- 
angles,  10 tiM  NDGA; inverted 
triangles,  20 ~M AA +  10 #M 
NDGA. B, Effect of AA and/or 
INDO  on  the  dose-response 
curve to ACh. Squares, control; 
circles, 20 #M A.A; triangles,  10 
tiM INDO; inverted triangles, 20 
uM AA +  10 #M INDO. 
pA,  compared  with  88.1  pA  for  1  #M  ACh),  although  the  major  effect  of AA 
metabolites  appears  to be in modulating the cellular response  to ACh. ACh, in the 
presence of AA, elicits a  smaller  peak IK[A~] and the current decays to significantly 
lower  steady-state  levels,  suggesting  that  AA  metabolites  may  modulate  IK[A~] 
desensitization. 
Metabolism  of AA Is Required 
Modulation of ion channel function by AA can proceed via either a  direct mecha- 
nism (Kim and Clapham,  1989; Ordway et al.,  1989; Vacher et al.,  1989) or through SCHERER AND BREITWIESER Arachidonic  Acid Alters Muscarinic K + Channel Activation  747 
the production of metabolites (Piomelli et al., 1987; Kim et al., 1989; Kurachi et al., 
1989). To assess the contribution of each of these possibilities to the effects of AA on 
IKfACh] activation, we (a) examined the effects of the metabolic inhibitors NDGA and 
INDO  on  the  response  to  AA,  and  (b)  tested  whether  AA  metabolites  could 
overcome the blocking effects of the inhibitors. 
Virtually  all  of  the  effects  of  AA  on  IK[ACh] activation  arc  mediated  by  AA 
metabolitcs. Both inhibitory and stimulatory metabolites are produced (as discussed 
below; see also Fig. 4). The effect of AA on the basal activation rate was blocked by 
NDGA to a level not statistically different from that found in the presence of NDGA 
alone (0.24 rain -1 [AA +  NDGA] vs. 0.21 rain -1  [NDGA alone]). If the block of the 
basal rate of activation of IKtACh] by NDGA results in a  residual rate that is due to 
direct effects of AA, then this effect is saturated by cellular AA levels, since addition 
of 20 #M exogenous AA did not significantly increase this rate, suggesting that all of 
the effects of AA are due to metabolites. 
Lipoxygenase Metabolites  Increase the Rate of IK[ACal Activation 
NDGA blocks lipoxygenases, and when added to the bath in the presence or absence 
of exogenous AA,  decreases  both  the  basal  and  ACh-augmented  rate  of IK[ACh] 
activation. NDGA reduced the amplitude of IK[ACh] activated via either ACh (+ GTP) 
(Scherer and Breitwieser, unpublished observations) or GTP3,S (see Fig. 9 A). All of 
the  effects of NDGA  are  reversed  by  the  5-1ipoxygenase  product,  LTC4.  These 
results  strongly suggest  that  products  of the  5-1ipoxygenasc pathway,  specifically 
sulfidopcptide leukotrienes, enhance the rate of Gk activation. The specific metabo- 
litcs  of NDGA-blockable pathways  that  modulate  G k are  not known  since  NDGA 
blocks not only 5-1ipoxygenase, but also 12-1ipoxygenase and epoxygenases (Needle- 
man et al.,  1986; Capdevila et al.,  1988). Although we find that LTC  4 reverses the 
effect of NDGA,  other leukotrienes or metabolites may be equally effective, since 
LTC4 breaks down readily to LTD4, LTE4, etc. 
Cydooxygenase  Metabolites  Decrease the Rate of Irdacal Activation 
INDO,  a  cyclooxygenase inhibitor,  consistently increased  both  the  basal  rate  of 
IK[ACh] activation in either the absence or presence of exogenously applied AA, and 
reversed the inhibitory effect of AA on the ACh-mediated augmentation of the basal 
activation rate. These results are consistent with the notion that a metabolite of the 
cyclooxygenase pathway  slows  the  rate  of G k activation.  A  complication  is  that 
diversion  of AA  into  the  lipoxygenase pathways  may occur upon  cyclooxygenase 
blockade  (Aehringhaus  et  al.,  1984),  thus  producing  more  of  the  stimulatory 
metabolites.  Two  of our  results  rule  out  diversion  of AA  into  the  stimulatory 
lipoxygenase pathway as the sole explanation for the effects of INDO and argue for 
the production of an inhibitory metabolite: first, INDO reverses the inhibition of the 
ACh-augmented  IK[ACa] activation rate  mediated  by exogenously applied AA;  and 
second,  INDO  greatly potentiates  the  effect of exogenously applied  LTC  4.  The 
cyclooxygenase metabolite(s) that inhibit I~ACh] activation are unknown since pros- 
taglandins,  thromboxanes, and  12-hydroxy-heptadecatrienoic acid are all produced 
via this  pathway.  Experiments  to identify the  cyclooxygenase pathway metabolites 
that inhibit Gk activation are underway. 748 
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FIGURE 9.  Effect  of  NDGA 
on  GTP3,S-activated  IKIAChJ" 
IK[ACh] was activated  by  1 mM 
GTP~S in  the intracellular  so- 
lution;  maximal IKCAChl was ob- 
tained by a brief pulse of 1 #M 
ACh,  which  was  then  washed 
from the bath. Illustrated  is the 
effect of switching to a Ringer 
solution  containing  NDGA 
plus various other effectors on 
the  GTP~,S-activated  current. 
A,  10  #M  NDGA;  B,  10  /~M 
NDGA plus  1 #M ACh; C,  10 
#M LTC  4 plus 10 #M NDGA. 
Mechanism of Action of AA Metabolites 
Our data would suggest that both lipoxygenase and cyclooxygenase products of AA 
modulate IKtACM through G k. Three configurations of a receptor-G protein-effector 
sigual-transducing pathway could account for our data, as diagrammed below, with 
LTR  representing  a  leukotriene  receptor,  LT representing  an  unspecified  leuko- 
triene,  and  PGH2X representing  one  or  more of the  metabolites  produced from 
prostaglandin H 2 (PGH2) via the cyclooxygenase pathway, which negatively modulate SCHERER AND BRI~rrwl,v.S~  Arachidonic Acid Alters Muscarinic K + Channel Activation  749 
the effects of LTR. Model 1 assumes mAChR and LTR converge at G k, with both 
receptors capable of increasing the rate of GDP release from G k.  Model 2  differs 
from model  1 in that mAChR and  LTR interact with distinct G  proteins, both of 
which are capable of activating IKtACh], and thus the two pathways converge at the 
level  of  the  channel.  Model  3  states  that  metabolites  of  AA  alter  the  kinetic 
properties of G k and affect its interactions with mAChR and/or the ion channel. 
Models 1 and 2 assume that the relevant LTR is coupled to a G protein. Although 
[3H]LTD4 binding in lung is modulated by guanine nucleotides, binding of LTC  4 is 
not,  suggesting  that  not  all  leukotriene  receptors  are  coupled  to  effectors via  G 
mAChR 
LTR  \ G 
PGH2X 
Model 1 
IK[ACh] 
mAChR 
LTR  + 
=  Gkl~~  IK[ACh] 
Gk2 
PGH2X 
Model 2 
mAChR  -- G k  "  IK[ACh] 
LT  PGH2X 
Model 3 
proteins (Hogaboom et al.,  1983). If the relevant LTR is coupled to a G protein, it 
cannot be Gk, since the effect of leukotrienes on single-channel IKtACh]  activation was 
not  blocked  by  pertussis  toxin  (PTX)  treatment  (Kurachi  et  al.,  1989),  which 
interferes with the interaction of receptors with G k (Pfaffinger et al., 1985). Model 1 
is thus ruled out. Model 2 is still plausible if it is assumed that Gk2 is not sensitive to 
PTX, and hence is not uncoupled from LTR by PTX treatment. 
Agonists  for  G  protein--coupled  receptors  act  to  enhance  GDP  release  from 
inactive G proteins. Once the G protein becomes activated with GTP~'S, removal of 
agonist (e.g., ACh) is without effect (Breitwieser and Szabo,  1985,  1988). Similarly, 750  THE JOURNAL  OF  GENERAL  PHYSIOLOGY ￿9 VOLUME  96  ￿9 1990 
removal of lipoxygenase products by addition of NDGA should be without effect if 
the leukotrienes are acting only by increasing the rate of GDP release from G k via a 
classical receptor-G protein interaction.  Fig.  9  illustrates the test of these predic- 
tions. In all three panels, lxtach~ was maximally activated by GTP',/S. NDGA was able 
to block the GTP'yS-activated IKEacal (Fig. 9 A). Addition of ACh with NDGA did not 
overcome the effect of NDGA (Fig. 9 B). LTC4, however, if added at the same time 
as  NDGA,  was  able  to prevent the  inhibition of the  GTP-yS-activated II~AChj (Fig. 
9 C),  and  indeed,  resulted  in  a  slight  increase  in  the  level  of GTP'yS-activated 
current. These results further rule out models 1 and 2, since in both cases one would 
expect uncoupling of all of the receptors from their respective G proteins once the 
G proteins had been activated by GTP~'S. 
Model 3 is the most parsimonious explanation of our data. We suggest that both 
lipoxygenase and cyclooxygenase metabolites directly modulate the functional state 
of G k.  These metabolites  produce  their effects on both the  inactive,  GDP-bound 
form of G k and on ak-GTPTS, suggesting that the ot subunit is modified. Modulation 
of GTPTS-activated IKEACal by AA metabolites requires that either (a)  the channel- 
associated ak-GTP-rS can still be modulated by AA metabolites or (b) there is a finite 
amount  of  dissociation  of  ak-GTP'yS  from  the  ion  channel  during  steady-state 
current  activation.  The  ability  of LTC  4 to  increase  steady-state,  GTPTS-activated 
I~:tA~l (Fig. 9 C) suggests it is able to promote ak-GTPTS -  channel association: 
ak-GTPyS +  channel  LTC~  channel  ￿9 ak-GTPyS, 
implying that both unassociated ak-GTP~rS and ion channels exist under steady-state 
conditions.  LTC  4 could  thus  increase  the  steady-state,  GTP-yS-activated IKt^Chl by 
shifting the equilibrium in favor of channel ￿9 otk-GTP3,S. This has implications for the 
physiological  activation  of IIqAC~1 by ACh.  As  illustrated  in  Fig.  2 A,  peak  IKtACh~ 
desensitizes to the steady-state current within the first 60 s after ACh application, 
implying that not all of the available ion channels are active during the steady state. 
Thus, both the net ability of Gk to activate l~r  J and desensitization may, in part, be 
the result of alterations in the balance of inhibitory and stimulator,/AA metabolites 
with time after mAChR activation. 
It is necessary to rule out direct modifications of either the ion channel or mAChR 
by AA  metabolites.  Several lines  of evidence suggest  that  the  ion  channel  is  not 
directly blocked or modulated by AA metabolites. Fig.  3  suggests that the GTPyS- 
activated current is not directly modulated by AA, and the results of Fig. 9, A and C 
suggest that NDGA does not produce its effects by directly blocking the ion channel, 
since LTC  4 is able to overcome the blocking effects. 
Our  results  rule  out  the  mAChR  as  the  major locus  of AA  metabolite action. 
While  AA  decreases  the  binding  of the  muscarinic  antagonist  [SH]quinuclidinyl- 
benzilate to cardiac  (Rauch et al.,  1989) or synaptic membranes  (Aronstam et al., 
1977),  it  has  also  been  reported  to  increase  binding  of the  muscarinic  agonist 
carbamylcholine (Baron and Kloog, 1984). Our results exclude an effect of AA or its 
metabolites at the agonist-binding site of mAChR binding,  since AA has the same 
effect(s) on the rate of IKtAChl activation in the absence or presence of atropine (10 
#M). In addition, the effects of AA metabolites and blockers on the ACh-augmented SCHERER AND BREITWIESER  Arachidonic Acid Alters Muscarinic K + Channel Activation  751 
rate of llqAChl activation can be predicted from their effects on the basal rate of G k 
activation, suggesting that mAChR is interacting normally with an altered G k. Finally, 
AA metabolites affect the GTP~S-activated IKt^Ch] (Fig. 9) under conditions in which 
mAChR is  uncoupled from G k.  Thus,  although we cannot at this time rule out a 
minor effect of AA and/or its metabolites on mAChR, our data would suggest that 
the primary site of action for AA and its metabolites is at the level of G k. 
It is of interest to speculate about the ways in which G k could be modified by AA 
and its metabolites. There have been reports of phosphorylation of G i in response to 
protein kinase C activation (Katada et al.,  1985). In addition, there is evidence that 
hydroperoxy acids decrease the activity of the calcium-calmodulin protein kinase II 
(Piomelli et al.,  1989). Therefore, it is possible that a tonic level of phosphorylation 
of G k is modulated by AA and its metabolites. It is also possible that some other type 
of  dynamic  covalent  modification  of  G k  occurs  in  response  to  the  balance  of 
stimulatory and  inhibitory metabolites  of AA that  are  present  in  the  membrane. 
Myristoylation (Buss et al.,  1987; James and Olson,  1989a), palmitoylation (James 
and Olson,  1989b) and farnesylation (Casey et al., 1989; Hancock et al., 1989) have 
all been described as regulated modifications of eukaryotic proteins, including ras 
(WiUumsen et al., 1984; Magee et al., 1987). Such lipid-mediated covalent modifica- 
tions may be the reason that cloned G i subtypes are much less potent at promoting 
activation of IKtACh] than  biochemically purified,  native  G  proteins  (Yatani  et  al., 
1988).  Alternately,  some  type  of noncovalent  interaction  of AA  metabolites  or 
further products with G k may occur. 
Comparison  with Excised Patch Results 
Our data confirm and extend the results of Kim et al.  (1989)  and  Kurachi et al. 
(1989): both groups have reported that AA and various lipoxygenase metabolites are 
capable  of stimulating  single-channel  IKtAC~], although  not  to  the  same  extent  as 
GTP3,S.  Our  results  confirm the  submaximal  stimulation  of IlqACh] by AA  at  the 
whole-cell level: 20 #M AA induced only 2-4 pA of IKEACh], compared with 88.1  pA 
inducible by ACh. The inability of AA to maximally activate whole-cell IKtAChJ in the 
absence  of ACh,  the  attenuation  of ACh-induced  II~[AChl by AA  (Fig.  2),  and  the 
influence of AA and metabolites on the rate of G k activation (e.g., Fig. 5) suggest that 
AA and metabolites play a modulatory role in IK[AO,] activation. Both Kurachi et al. 
(1989) and Kim et al.  (1989) have demonstrated stimulatory effects of lipoxygenase 
metabolites. Kurachi et al.  (1989) concluded that these metabolites either enhance 
GDP/GTP exchange of Gk in a  receptor-independent manner, or that they couple 
directly to the channel via membrane receptors interacting with PTX-insensitive G 
proteins.  Our results demonstrate that lipoxygenase metabolites increase the GDP 
release rate from G k and thus modulate IKEACh]. Our data also provide an explanation 
for the observation of Kurachi et al. (1989) of the slight stimulatory effect of INDO 
on single-channel IKEAChl. Since cyclooxygenases are present in endoplasmic reticu- 
lum (Needleman et al., 1986), one might expect a greater contribution of inhibitory 
metabolites in the whole-cell recording configuration. Our whole-cell data define a 
distinct inhibitory role for cyclooxygenase products in modulating IKEA~  ] and suggest 
that IKt^Ch] is dynamically regulated by the balance of stimulatory and inhibitory AA 
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Physiological  Implications 
We have shown that metabolites of AA specifically modulate IKEAC~I and suggest that 
they act by altering the kinetic properties of G k.  Stimulation of mAChR results in 
activation of IKtAC~1, inhibition of adenylate cyclase, and stimulation of phosphatidyl- 
inositol metabolism. All of these effects are mediated by G proteins and thus may be 
subject to modulation by AA. Physiological responses to ACh such as alterations in 
heart rate, contractility, and conduction velocity may also be affected by AA. 
The results we have obtained in the presence of exogenously applied AA may be 
more relevant to pathological states, in which large amounts of AA and metabolites 
are produced. For example, exogenously generated leukotrienes have been shown to 
alter cardiac performance. Leukotrienes (LTC  4 and LTD4) are produced in isolated 
heart preparations  in response to antigenic stimulation  (Aehringhaus et al.,  1983; 
Levi et al., 1985; Yacoob and Piper, 1988) or during myocardial infarction (Evers et 
al.,  1985).  Although  all  of the  leukotrienes  produced  during  pathophysiological 
states may not be produced by the myocytes, leukotrienes do impinge directly on 
cardiac  muscle,  probably  through  specific  receptors  (Hogaboom  et  al.,  1985), 
resulting in a  negative inotropic effect (Hattori and Levi,  1984;  Levi et al.,  1985; 
Bjornsson et al., 1987). Our data would suggest that part of the mechanism by which 
leukotrienes  reduce  myocardial  contractility  may  be  modulation  of  IKEAC~1, and 
possibly other second messenger pathways. 
There also appears to be a defined role for AA metabolism under nonpathological 
states. The effects of NDGA and INDO on llctA~l activation rates in the absence of 
exogenous AA  suggest  that  cellular metabolism of AA contributes to the  normal 
functioning of G k and of the signal transduction pathway, which ultimately activates 
IKtAChJ" Since prostaglandins are produced by isolated hearts in response to musca- 
rinic receptor stimulation (Jaiswal and Malik,  1988), it is likely that modulation of 
IKEAC~I by AA metabolites occurs as a  normal consequence of mAChR stimulation. 
Indeed, lipoxygenase products of AA metabolism may be necessary for full expres- 
sion  of IIqAC~I, since  IKEAChl is  greatly  attenuated  by  NDGA.  Finally,  AA  release 
resulting from activation of phospholipase A 2 or phospholipase C plus diacylglycerol 
lipase  (Burch,  1989) via other receptor systems may modulate IKtAChl indirectly by 
altering Gk responsiveness to mAChR stimulation. 
We  thank  Dr.  Dan  Raben  for helpful  discussions and  Leora Hamosh  for excellent technical 
assistance. 
This work was supported by a  Grant-in-Aid from the American Heart Association with funds 
contributed  in  part by the American  Heart Association, Texas Affiliate, Inc.,  and NIH grant 
HL-41972  to G.E.B.R.W.S.  is  supported in  part by a  fellowship from the American  Heart 
Association, Maryland Affiliate. 
Original version received 8 February 1990 and accepted version received 17 May 1990. 
REFERENCES 
Aehringhaus, U., A. Dembinska-Kiec,  and B. A. Peskar. 1984. Effects of exogenous prostaglandins 
on the release of leukotriene C4dike immunoreactivity and on coronary flow in indomethacin- 
treated anaphylactic guinea-pig hearts. Naunyn-Schmiedeberg's Archives of Pharmacology. 326:368- 
374. SCHERER AND BREITWIESER  Arachidonic Acid Alters Muscarinic K + Channel Activation  753 
Aehringhaus, U., B. A. Peskar, H. R. Wittenberg, and R. H. Wolbling. 1983. Effect of inhibition  of 
synthesis and receptor anatagonism of SRS-A in cardiac anaphylaxis. British Journal of Pharmacol- 
ogy. 80:73-80. 
Aronstam, R. S., L. G. Abood, andJ. Baumgold.  1977. Role of phospholipids  in muscarinic binding 
by neural membranes. Biochemical Pharmacology. 26:1689-1695. 
Baron,  B.,  and Y.  Kloog.  1984.  Fatty acid  incorporation increases  the  affinity  of muscarinic 
cholinergic receptors for agonists. Blochimica et Biophysica Acta. 801:342-350. 
Bjornsson, O. G., K. Kobayashi, and J. R. Williamson. 1987. Inducers of adenylate cydase reverse 
the effect of ieukotriene D  4 in isolated working guinea pig heart. American Journal  of Physiology 
(Heart and Circulatory Physiology). 252:H1235-H1242. 
Breitwieser,  G.  E.,  and  G.  Szabo.  1985.  Uncoupling of cardiac  muscarinic and /~-adrenergic 
receptors from ion channels by a guanine nucleotide analogue. Nature. 317:538-540. 
Breitwieser,  G. E., and G. Szabo.  1988.  Mechanism  of muscarinic receptor-induced K  + channel 
activation  as  revealed  by  hydrolysis-resistant  GTP  analogues.  Journal  of General Physiology. 
91:469-493. 
Brown, A. M., and L. Birnbanmer. 1988. Direct G protein gating of ion channels. American Journal 
of Physiology (Heart and Circulatmy Physiology). 254:H401 -H410. 
Burch,  R. M.  1989. G protein regulation of phospholipase  A~. Molecular Neurobiology. 3:155-171. 
Buss, J.  E., S.  M.  Mumby,  P. J.  Case)', A. G. Gilman, and B.  M. Sefton.  1987.  Myristoylated 
subunits of guanine nudeotide-binding  regulatory proteins. Proceedings of the National Academy of 
Sciences USA. 84:7493-7497. 
Capdevila, J., L. Gil, M. Orellana, L. J. Marnett, J. I. Mason, P. Yadagiri, and J.  R. Falck. 1988. 
Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Archives of Biochemistry 
and Biophysics. 261:257-263. 
Casey, P.J., P. A. Solski, C.J. Der, andJ. E. Buss. 1989. p21ras is modified by a farnesyl isoprenoid. 
Proceedings of the National Academy of Sciences USA. 86:8323-8327. 
Evers,  A.  S.,  S.  Murphree, J.  E.  Saffitz, B.  A. Jakschik,  and P.  Needleman.  1985.  Effects  of 
exogenously  produced  leukotrienes, thromboxane, and prostaglandins on coronary vascular 
resistance in rabbit myocardial infarction.  Journal of Clinical Investigation. 75:992-999. 
Fischmeister,  R.,  and H.  C.  Hartzell.  1986.  Mechanism  of action of acetylcholine  on calcium 
current in single cells from frog ventricle. Journal of Physiology. 376:183-202. 
Gamier,  D.,  J.  Nargeot,  C.  Ojeda,  and  O.  Rougier.  1978.  The  action  of  acetylcholine  on 
background conductance in frog atrial trabeculae. Journal of Physiology. 274:381-396. 
Hamill, O. P., A. Mart)', E. Neher, B. Sakmann, and F. J. Sigworth.  1981. Improved patch-clamp 
techniques for high-resolution current recording from cells and cell-free  membrane patches. 
PflVtgers Archiv.  391:85-100. 
Hancock, J.  F.,  A.  I.  Magee,  J.  E.  Childs,  and  C.  J.  Marshall.  1989.  All  ras  proteins  are 
polyisoprenylated  but only some are palmitoylated.  Cell. 57:1167-1177. 
Hattori, Y., and R. Levi. 1984.  Negative inotropic effect of leukotrienes:  leukotrienes C  4 and D  4 
inhibit calcium-dependent contractile responses in potassium-depolarized  guinea-pig myocar- 
dium. The Journal of Pharmacology and Experimental Therapeutics. 230:646-651. 
Hogaboom,  G.  K.,  S.  Mong,  J.  M.  Stadel,  and  S.  T.  Crooke.  1985.  Characterization  of 
[SH]Leukotriene D4 binding  sites in guinea-pig  ventricular  myocardium.  The Journal of Pharmacol- 
ogy and Experimental Therapeutics. 233:686-693. 
Hogaboom, G.  K., S.  Mong,  H.-L.  Wu, and S.  T.  Crooke.  1983.  Peptidoleukotrienes: distinct 
receptors for leukotriene C  4 and D  4 in the guinea-pig lung. Biochemical and Biophysical Research 
Communications. 116:1136-1143. 754  TH~ JOURNAL OF GENERAL PHYSIOLOGY ￿9 VOLUME 96 ￿9 1990 
Jaiswal, N., and K. U. Malik. 1988. Prostaglandin synthesis elicited by cholinergic stimuli is mediated 
by  activation of  M 2  muscarinic receptors  in  rabbit  heart.  The Journal  of Pharmacology and 
Experimental Therapeutics. 245:59-66. 
James, G., and E. N. Olson. 1989a. Myristoylation, phosphorylation, and subcellular distribution of 
the  80-kDa  protein  kinase  C  substrate  in  BCsH1  myocytes. Journal  of Biological  Chemistry. 
264:20928-20933. 
James, G., and E. N. Olson. 1989b.  Identification of a novel fatty acylated protein that partitions 
between the plasma membrane and cytosol and is deacylated in response to serum and growth 
factor stimulation.  Journal of Biological Chemistry. 264:20998-21006. 
Jelsema, C. L., andJ. Axelrod. 1987. Stimulation of phospholipase A2 activity in bovine rod outer 
segments by the fl~, subunits of transducin and its inhibition by the ot subunit. Proceedings of the 
National Academy of Sciences USA. 84:3623-3627. 
Katada,  T., A.  G.  Gilman, Y.  Watanabe, S.  Bauer,  and K.  H. Jakobs.  1985.  Protein kinase C 
phosphorylates the inhibitory guanine-nucleotideobinding  regulatory component and apparently 
suppresses its function in hormonal inhibition of adenylate cyclase. EuropeanJourual  of Biochemis- 
try. 151:431-437. 
Kim, D., and D. E. Clapham. 1989. Potassium channels in cardiac cells activated by arachidonic acid 
and phospholipids. Sc/ence. 244:1174-1176. 
Kim, D., D. L. Lewis,  L. Graziadei, E. J. Neer, D. Bar-Sagi, and D. E. Clapham.  1989. G-protein 
fl"f-subunits activate the cardiac muscarinic K+-channel via phospholipase A 2. Nature.  337:557- 
560. 
Kurachi,  Y.,  H.  Ito,  T.  Sugimoto,  T.  Shimizu,  I.  Mild,  and  M.  Ui.  1989.  Arachidonic  acid 
metabolites as  intracellular modulators  of the  G  protein-gated cardiac  K +  channel. Nature. 
337:555-557. 
Levi, R., Y. Hattori, J. A. Burke, Z.-G. Guo, U. Hachfeld del Balzo, W. A. Scott, and G. A. Rouzer. 
1985.  Leukotriene C 4 is  released from  the  anaphylactic heart:  a  case  for  its  direct  negative 
inotropic effect.  In  Prostaglandins, Leukotrienes, and Lipoxins: Biochemistry,  Mechanism of 
Action, and Clinical Applications. J.  M.  Bailey,  editor.  Plenum Publishing Corp.,  New  York. 
275-288. 
Logothetis, D. E., Y. Kurachi, J. Galper, E.J. Neer, and D. E. Clapham. 1987. The/3"y subunits of 
GTP-binding proteins activate the muscarinic K + channel in heart. Nature. 325:321-326. 
Magee, A. I., L. Gutierrez, I. A. McKay, C.J. Marshall, and A. Hall. 1987. Dynamic fatty acylation 
of p21N~. The EMBOJournal.  6:3353-3357. 
Needleman, P., J. Turk, B. A. Jakschik, A. R. Morrison, and J. B. Lefkowith. 1986. Arachidonic acid 
metabolism. Annual Review of Biocheraistry. 55:69-102. 
Neer, E. J., and D.  E. Clapham. 1988. Roles of G  protein subunits in transmembrane signalling. 
Nature. 333:129-134. 
Ordway,  R. W., J.  V.  Walsh, Jr.,  and J. J.  Singer.  1989.  Arachidonic acid and other fatty acids 
directly activate potassium channels in smooth muscle cells. Science. 244:1176-1179. 
Pfaffinger, P. J., J.  M. Martin, D. D. Hunter, N. M. Nathanson, and B. Hille. 1985. GTP-binding 
proteins couple cardiac muscarinic receptors to a K channel. Nature.  317:536-538. 
Piomelli, D., A. Volterra, N. Dale, S. A. Siegelbanm, E. R. Kandel,  J. H. Schwartz, and F. Belardetti. 
1987.  Lipoxygenase  metabolites  of  arachidonic  acid  as  second  messengers  for  presynaptic 
inhibition of Aplysia sensory cells. Nature. 328:38-43. 
Piomelli, D., J.  K. T. Wang, T.  S.  Sihra, A.  C.  Nairn, A. J.  Czernik, and P.  Greengard.  1989. 
Inhibition of Ca  + +/calmodulin-dependent protein kinase II by arachidonic acid and its metabo- 
lites. Proceedings of the National Academy of Sciences USA. 86:8550-8554. SCHEI~R AND BRIErrwIKsEIt  Arachidonic Acid Alters Muscarinic K + Channel Activation  755 
Ranch,  B.,  R.  A.  Colvin,  and F.  C.  Messineo.  1989.  Inhibition of [SH]quinuclidinyl benzylate 
binding to cardiac  muscarinic receptor by long chain fatty acids can be attenuated by ligand 
occupation of the receptor. Journal of Molecular and Cellular Cardiology. 21:495-506. 
Scherer,  R. W.,  and G.  E.  Breitwieser.  1990.  Arachidonic acid and LTC4 modulate muscarinic 
potassium channel activation in heart. Biophysical  Journal. 57:313a.  (Abstr.) 
Simmons, M. A., and H. C. Hartzell.  1987.  A quantitative analysis of the acetylcholine-activated 
potassium current in single cells from frog atrium. Pfl~gers Archly. 409:454-461. 
Soejima,  M.,  and A.  Noma.  1984.  Mode  of regulation of the ACh-sensitive  K-channel by the 
muscarinic receptor in rabbit atrial cells. Pflfigers Archiv. 400:424-431. 
Szabo, G., and A. S. Otero. 1989. Muscarinic activation of potassium channels in cardiac myocytes: 
kinetic aspects of G protein function in vivo. Trends in Pharmacological Sciences. 10 (Suppl):46-49. 
Vacher, P., J. McKenzie, and B. Duly. 1989. Arachidonic acid affects membrane ionic conductances 
of GH  s pituitary cells. American Journal  of Physiology (Endocrinology and Metabolism). 257:E203- 
E211. 
Willumsen, B. M., A. Christensen, N. L. Hubbert, A. G. Papageorge,  and D. R. Lowy. 1984. The 
p21 ras C-terminus is required for transformation and membrane association. Nature. 310:583- 
586. 
Yacoob, H. B., and P. J. Piper. 1988. Inhibition of leukotriene release in anaphylactic guinea-pig 
hearts by a 5-1ipoxygenase inhibitor, CGS 8515. British Journal of Pharmacology. 95:1322-1328. 
Yatani, A., J. Codina, A. M. Brown, and L. Birnbaumer. 1987. Direct activation of mammalian  atrial 
muscarinic potassium channels by GTP regulatory protein G  k. Sc/ence. 235:207-211. 
Yatani, A., R. Mattera, J. Codina, R. Graf, IL Okabe, E. PareU, R. Iyengar, A. M. Brown, and L. 
Birnbaumer.  1988.  The  G  protein-gated atrial  K  +  channel is  stimulated by  three  distinct 
Gicx-subunits.  Nature. 336:680-682. 